Advanced search
Publication Cover
Free Radical Research Volume 23, 1995 - Issue 5
Submit an article Journal homepage
7
Views
27
CrossRef citations to date
0
Altmetric
Original Article

A New Nitric Oxide (No) Releaser: Spontaneous No Release from Fk409

Shinichi Fukuyama Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Yasuhiro Kita New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Yoshimi Hirasawa New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Toshio Azuma Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Akihiro Sato Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Noritugu Morokoshi Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Shigetaka Koda Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Tsutomu Yasuda Analytical Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka, 532, Japan
,
Shigenori Oka Department of Analytical Chemistry, Kyoto Pharmaceutical University, Nakauchi-cho 5, Misasagi, Yamashina-ku, Kyoto, 607, Japan
&
Hiromu Sakurai Department of Analytical Chemistry, Kyoto Pharmaceutical University, Nakauchi-cho 5, Misasagi, Yamashina-ku, Kyoto, 607, Japan
 show all
Pages 443-452 | Received 26 Sep 1994, Published online: 07 Jul 2009

References

  • Hino M., Iwami M., Okamoto M., Yoshida K., Haruta H., Okuhara M., Hosoda J., Kohsaka M., Aoki H., Imanaka H. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy., fermentation, isolation and physio-chemical and biological characteristics. Journal of Antibiotics 1989; 42: 1578–1583
  • Yamada H., Yoneyama F., Satoh K., Taira N. Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog. British Journal of Pharmacology 1991; 103: 1713–1718
  • Sibata S., Sakate N., Sato N., Matsuo M., Koibuchi Y., Hester R. K. Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries. Journal of Cardiovascular Pharmacology 1991; 17: 508–518
  • Katsuki S., Arnord W., Mittal C., Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. Journal of Cyclic Nucleotide Research 1977; 3: 23–25
  • Schultz K. D., Schultz K., Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977; 265: 750–751
  • Galvas P. E., DiSalvo J. Concentration and time-dependent relationships between isosorbide dinitrite-induced relaxation and formation of cyclic GMP in coronary arterial smooth muscle. Journal of pharmacology and Experimental Therapeutics 1983; 224: 373–378
  • Murad F., Mittal C. K., Arnold W. P., Katsuki S., Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Advanced Cyclic Nucleotide Research 1978; 9: 145–158
  • Kita Y., Hirasawa Y., Maeda K., Nishio E., Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. European Journal of Pharmacology 1994; 257: 123–130
  • Kita Y., Sugimoto T., Hirasawa Y., Yoshida K., Maeda K. Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level. British Journal of Pharmacology 1994; 113: 5–6
  • Kita Y., Hirasawa Y., Yoshida K., Maeda K. Antiplatelet activities of FK409, a new spontaneous NO releaser. British Journal of Pharmacology 1994; 113: 385–388
  • Kita Y., Ozaki R., Sakai S., Sugimoto T., Hirasawa Y., Ohtsuka M., Senoh H., Yoshida K., Maeda K. Antianginal effects of FK409, a new spontaneous NO releaser. British Journal of Pharmacology 1994; 113: 1137–1140
  • Palmer R. M.J., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526
  • Feelish M., Noack E. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. European Journal of Pharmacology 1987; 139: 19–30
  • Feelish M., Noack E. Nitric oxide (NO) formation from nitrovasodiators occurs independently of hemoglobin or non-heme iron. European Journal of Pharmacology 1987; 142: 465–469
  • Chong S., Fung H. L. Biochemical and pharmacological interactions between nitroglycerin and thiols. BiochemicalPrarmacology 1991; 42: 1433–1439
  • Feelish M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. Journal of Cardiovascular Pharmacology 1991; 17(Suppl.3)S25–S33
  • Akaike T., Yoshida M., Miyamoto Y., Sato K., Kohno M., Sasamoto K., Miyazali K., Ueda S., Maeda H. Antagonistic action of imidazolineoxylN-oxides against endothelium derived relaxing factor / NO through a radical reaction. Biochemistry 1993; 32: 827–832
  • Bell F. K., O'neill J. J., Burgison R. M. Determination of the oil /water distribution coefficients of glyceryl trinitrate and two similar nitrate esters. Journal of Pharmaceutical Science 1963; 52: 637–639
  • Az-Ma T., Fujii K., Yuge O. Reaction between imidazolineoxil N-oxide (carboxy-PTIO) and nitric oxide released from cultured endothelial cells: Quantitative measurement of nitric oxide by ESR spectroscopy. Life Sciences 1994; 54: PL185–190

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.